Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(675)
- Cyclic GMP-AMP Synthase(6)
- TLR(121)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(12)
- IκB/IKK(68)
- AP-1(11)
- KEAP1-Nrf2(56)
- NOD1(1)
- NF-κB(304)
- Interleukin Related(263)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(40)
- CD73(15)
- Complement System(69)
- Galectin(12)
- IFNAR(54)
- NO Synthase(93)
- NOD-like Receptor (NLR)(66)
- STING(118)
- Reactive Oxygen Species(505)
- FKBP(15)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(94)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(109)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(5)
- CD20(10)
- CD28(3)
- PSMA(12)
- FAP(16)
- Nuclear Factor of activated T Cells (NFAT)(2)
- Glycoprotein VI(2)
- Tim3(3)
- Hapten(1)
- Nectin-4(2)
- DOCK(1)
- MHC(9)
- Transmembrane Glycoprotein(17)
- TREM receptor(9)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(11)
- IKZF Family(4)
- C-type Lectin-like Receptors (CTLRs)(3)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4435)
- GC81862YJ1206 TFAPurity: >98.00%
YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader.
- GC818643BP-3580 TFAPurity: >98.00%
3BP-3580 TFA (compound 11) is a conjugate targeting FAP that binds to FAP-positive cells via the FAPI moiety and internalizes, delivering the payload to FAP -expressing cells, thereby inhibiting RA FLS proliferation, migration, and invasion, reducing inflammatory cytokine expression, and suppressing pannus formation.
- GC81873Ciprofloxacin hydrochlorideCAS: 86483-48-9Purity: >98.00%
Ciprofloxacin hydrochloride (Bay-09867 hydrochloride) is an orally active, blood-brain barrier permeable fluoroquinolone antibacterial agent.
- GC81880OSU-2S TFAPurity: >98.00%
OSU-2S TFA is a non-immunosuppressive derivative of Fingolimod hydrochloride (FTY720).
- GC81890Temozolomide-¹⁵NPurity: >98%
Temozolomide - 15 N (NSC 362856- 15 N) is the 15 N-labeled Temozolomide.
- GC81891Tri-GalNAc-NH2CAS: 1646198-77-7Purity: >98%
Tri-GalNAc-NH2 is a synthetic tri-N-acetylgalactosamine ligand that targets the asialoglycoprotein receptor (ASGPR).
- GC90022(±)-Norepinephrine-d6 (hydrochloride)CAS: 1219803-04-9Purity: >99.00%
Un standard interne pour la quantification de la norépinéphrine.
- GC90030DemethoxycurcuminCAS: 22608-11-3Purity: >98.00%
Curcuminoïde naturel avec des rôles dans le cancer et l'inflammation.
- GC90077Furin Inhibitor I (trifluoroacetate salt)Purity: >95.00%
Un inhibiteur de proprotéine convertase
- GC90195Posaconazole-d5CAS: 2649530-57-2Purity: >98.00%
Un standard interne pour la quantification du posaconazole.
- GC90243Myelin Basic Protein (human, bovine, rat) (trifluoroacetate salt)Purity: >95.00%
Un peptide encéphalitogène
- GC90489AC 187 (trifluoroacetate salt)Purity: >95.00%
Un antagoniste des récepteurs de la calcitonine et de l'amyline.
- GC90508Ala-D-γ-Glu-Lys-D-Ala-D-Ala (trifluoroacetate salt)CAS: 62182-55-2Purity: >98.00%
Un pentapeptide de peptidoglycane
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC81862 | YJ1206 TFA | - | >98.00% | |
YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader. | ||||
| GC81864 | 3BP-3580 TFA | - | >98.00% | |
3BP-3580 TFA (compound 11) is a conjugate targeting FAP that binds to FAP-positive cells via the FAPI moiety and internalizes, delivering the payload to FAP -expressing cells, thereby inhibiting RA FLS proliferation, migration, and invasion, reducing inflammatory cytokine expression, and suppressing pannus formation. | ||||
| GC81872 | CPTH2-d₄ | - | >98% | |
CPTH2 -d 4 is the deuterated-labeled CPTH2. | ||||
| GC81873 | Ciprofloxacin hydrochloride | 86483-48-9 | >98.00% | |
Ciprofloxacin hydrochloride (Bay-09867 hydrochloride) is an orally active, blood-brain barrier permeable fluoroquinolone antibacterial agent. | ||||
| GC81879 | NCP26 TFA | - | >99.50% | |
NCP26 TFA is an ATP-competitive ProRS inhibitor (with a K D of 271 nM in the absence of proline, and a K D of 0.35 nM in the presence of 100 μM proline). | ||||
| GC81880 | OSU-2S TFA | - | >98.00% | |
OSU-2S TFA is a non-immunosuppressive derivative of Fingolimod hydrochloride (FTY720). | ||||
| GC81890 | Temozolomide-¹⁵N | - | >98% | |
Temozolomide - 15 N (NSC 362856- 15 N) is the 15 N-labeled Temozolomide. | ||||
| GC81891 | Tri-GalNAc-NH2 | 1646198-77-7 | >98% | |
Tri-GalNAc-NH2 is a synthetic tri-N-acetylgalactosamine ligand that targets the asialoglycoprotein receptor (ASGPR). | ||||
| GC81898 | LLC355 | - | >99.50% | |
LLC355 is a discoidin domain receptor 1 ( DDR1 ) ATTEC degrader with a DC 50 of 150.8 nM. | ||||
| GC90022 | (±)-Norepinephrine-d6 (hydrochloride) | 1219803-04-9 | >99.00% | |
Un standard interne pour la quantification de la norépinéphrine. | ||||
| GC90030 | Demethoxycurcumin | 22608-11-3 | >98.00% | |
Curcuminoïde naturel avec des rôles dans le cancer et l'inflammation. | ||||
| GC90076 | HA-14-1 | 927635-64-1 | >95.00% | |
Un inhibiteur de Bcl-2 | ||||
| GC90077 | Furin Inhibitor I (trifluoroacetate salt) | - | >95.00% | |
Un inhibiteur de proprotéine convertase | ||||
| GC90195 | Posaconazole-d5 | 2649530-57-2 | >98.00% | |
Un standard interne pour la quantification du posaconazole. | ||||
| GC90243 | Myelin Basic Protein (human, bovine, rat) (trifluoroacetate salt) | - | >95.00% | |
Un peptide encéphalitogène | ||||
| GC90363 | 10(11)-Cl-BBQ | - | >95.00% | |
Un mélange qui agit comme un agoniste de l'AhR. | ||||
| GC90483 | Magainin 1 (trifluoroacetate salt) | - | >95.00% | |
Un peptide cationique antimicrobien | ||||
| GC90488 | Tat-Beclin 1 (acetate) | - | >98.00% | |
Un peptide inducteur d'autophagie | ||||
| GC90489 | AC 187 (trifluoroacetate salt) | - | >95.00% | |
Un antagoniste des récepteurs de la calcitonine et de l'amyline. | ||||
| GC90490 | PMX-53 (trifluoroacetate salt) | 514814-99-4 | >95.00% | |
Un antagoniste du récepteur C5a | ||||
| GC90496 | β-Cortolone | 667-66-3 | >95.00% | |
Un métabolite du cortisol | ||||
| GC90508 | Ala-D-γ-Glu-Lys-D-Ala-D-Ala (trifluoroacetate salt) | 62182-55-2 | >98.00% | |
Un pentapeptide de peptidoglycane | ||||
| GC90516 | VK-II-86 | 955371-84-3 | >90.00% | |
Un inhibiteur de SOICR | ||||
| GC90526 | st-Ht31 (ammonium salt) | - | >98.00% | |
Un peptide stéaré perméable à la cellule. | ||||
